Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET

被引:18
|
作者
Leung, Kevin H. [1 ,2 ]
Rowe, Steven P. [2 ,3 ,4 ]
Leal, Jeffrey P. [2 ]
Ashrafinia, Saeed [2 ]
Sadaghiani, Mohammad S. [2 ]
Chung, Hyun Woo [5 ]
Dalaie, Pejman [2 ]
Tulbah, Rima [2 ]
Yin, Yafu [6 ]
VanDenBerg, Ryan [2 ]
Werner, Rudolf A. [7 ]
Pienta, Kenneth J. [3 ,4 ]
Gorin, Michael A. [8 ]
Du, Yong [2 ]
Pomper, Martin G. [1 ,2 ,3 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 601 N Caroline St,JHOC 4263, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA
[5] Konkuk Univ, Sch Med, Med Ctr, Dept Nucl Med, Seoul, South Korea
[6] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Nucl Med, Shanghai, Peoples R China
[7] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany
[8] Icahn Sch Med Mt Sinai, Milton & Carroll Petrie Dept Urol, New York, NY USA
基金
美国国家卫生研究院;
关键词
PSMA-RADS; PSMA PET; Deep learning; Classification; t-SNE; Prostate cancer; LESIONS; IMAGES;
D O I
10.1186/s13550-022-00948-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Accurate classification of sites of interest on prostate-specific membrane antigen (PSMA) positron emission tomography (PET) images is an important diagnostic requirement for the differentiation of prostate cancer (PCa) from foci of physiologic uptake. We developed a deep learning and radiomics framework to perform lesion-level and patient-level classification on PSMA PET images of patients with PCa. Methods: This was an IRB-approved, HIPAA-compliant, retrospective study. Lesions on [F-18]DCFPyL PET/CT scans were assigned to PSMA reporting and data system (PSMA-RADS) categories and randomly partitioned into training, validation, and test sets. The framework extracted image features, radiomic features, and tissue type information from a cropped PET image slice containing a lesion and performed PSMA-RADS and PCa classification. Performance was evaluated by assessing the area under the receiver operating characteristic curve (AUROC). A t-distributed stochastic neighbor embedding (t-SNE) analysis was performed. Confidence and probability scores were measured. Statistical significance was determined using a two-tailed t test. Results: PSMA PET scans from 267 men with PCa had 3794 lesions assigned to PSMA-RADS categories. The framework yielded AUROC values of 0.87 and 0.90 for lesion-level and patient-level PSMA-RADS classification, respectively, on the test set. The framework yielded AUROC values of 0.92 and 0.85 for lesion-level and patient-level PCa classification, respectively, on the test set. A t-SNE analysis revealed learned relationships between the PSMA-RADS categories and disease findings. Mean confidence scores reflected the expected accuracy and were significantly higher for correct predictions than for incorrect predictions (P < 0.05). Measured probability scores reflected the likelihood of PCa consistent with the PSMA-RADS framework. Conclusion: The framework provided lesion-level and patient-level PSMA-RADS and PCa classification on PSMA PET images. The framework was interpretable and provided confidence and probability scores that may assist physicians in making more informed clinical decisions.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories
    Yin, Yafu
    Werner, Rudolf A.
    Higuchi, Takahiro
    Lapa, Constantin
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (04) : 511 - 516
  • [32] Indeterminate skeletal and lymph node lesion on 18F PSMA 1007 PET/CT scanning: lessons from a review at 12 months with PSMA-RADS
    Bhoil, Amit
    Seshadri, Nagabhushan
    Vinjamuri, Sobhan
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (09) : 1034 - 1041
  • [33] Image-based PSMA PET/MRI deep learning model for automatic prostate cancer grading
    Solari, E.
    Schachoff, S.
    Rauscher, I.
    Eiber, M.
    Weber, W.
    Navab, N.
    Nekolla, S. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S320 - S321
  • [34] COMPARISON OF PSMA PET/CT, PSMA PET/MR AND MULTIPARAMETRIC MR IN THE DETECTION OF PRIMARY PROSTATE CANCER
    Thomas, P.
    Rhee, H.
    Shepherd, B.
    Gustafson, S.
    Miles, K.
    Paterdis, J.
    Russell, P. J.
    Nelson, C.
    Vela, I.
    Wood, S.
    Heathcote, P.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 16 - 16
  • [35] PSMA PET–CT in initial prostate cancer staging
    Frederik A. Verburg
    Andreas Pfestroff
    Nature Reviews Urology, 2016, 13 : 498 - 499
  • [36] Current status of PSMA PET imaging in prostate cancer
    Ho, Chi Lai
    Wu, Kwan Kit
    Chen, Sirong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 7 - 11
  • [37] Cu-64 PSMA PET in Prostate Cancer
    Mirzaei, S.
    Grubmueller, B.
    Capasso, E.
    Knoll, P.
    Floth, A.
    Meleddu, C.
    Shariat, S.
    Klingler, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S675 - S675
  • [38] Current use of PSMA–PET in prostate cancer management
    Tobias Maurer
    Matthias Eiber
    Markus Schwaiger
    Jürgen E. Gschwend
    Nature Reviews Urology, 2016, 13 : 226 - 235
  • [39] Prognostic Value of PSMA PET/CT in Prostate Cancer
    Lawal, Ismaheel O.
    Ndlovu, Honest
    Kgatle, Mankgopo
    Mokoala, Kgomotso M. G.
    Sathekge, Mike M.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 46 - 59
  • [40] Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?
    Laudicella, Riccardo
    Bauckneht, Matteo
    Burger, Irene A.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 87 - 96